Article: Peripheral benzodiazepine receptor deregulation increases tumorigenicity.

2004 DEC 7 - (NewsRx.com & NewsRx.net) -- Peripheral benzodiazepine receptor deregulation increases tumorigenicity.

"Peripheral benzodiazepine receptors (PBR), first described more than 20 years ago, have been attributed with many putative functions, including ones in cellular proliferation and cellular respiration. Hence, it is quite conceivable that deregulation of this receptor could lead to pathology," investigators in Israel report.

"We and others have reported the existence of PBR overexpression in different human and nonhuman malignancies, but it has never been made clear whether this aberrant malignant PBR expression is a cause or consequence of ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!